NCT05057130 2024-04-01
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
Clinical Trials
96 trialsNCT05057195 2024-04-01
Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy
Blokhin's Russian Cancer Research Center
Phase NA Unknown
NCT03818412 2024-03-22
Circulating Tumor DNA in Soft Tissue Sarcoma
University Health Network, Toronto
Phase NA Unknown
NCT06291662 2024-03-04
Evaluation of Performance Characteristics and Applicability in Oncology of Devices Customized Medical Devices Made by 3D Printing
Meyer Children's Hospital IRCCS
Phase NA Unknown
NCT03242382 2024-01-23
PalboSarc
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Unknown
NCT04025931 2023-12-29
Chidamide Combined With Toripalimab in Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05549921 2023-12-27
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT06114173 2023-11-02
Efficacy and Safety Study of Cardunilizumab in Soft Tissue Sarcoma
Xiangya Hospital of Central South University
Phase EARLY_PHASE1 Unknown
NCT04893356 2023-10-30
MGMT
National Cancer Institute, Naples
Unknown
NCT05684874 2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA Unknown
NCT06076070 2023-10-10
PROGEN_SARC
Regina Elena Cancer Institute
Unknown
NCT04367779 2023-09-13
PROTONBIOMARKS
Centre Leon Berard
Unknown
NCT04741438 2023-08-30
RAR-Immune
Centre Leon Berard
Phase 3 Unknown
NCT04510714 2023-08-03
BORIS
Instituto do Cancer do Estado de São Paulo
Phase NA Unknown
NCT03890068 2023-08-01
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05952128 2023-07-19
Phase Ib/II Study of Fluzoparib in Combination With Dalpiciclib in Patients With Locally Advanced or Metastatic Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT03462316 2023-04-12
NY-ESO-1-specific T Cell Receptor (TCR) T Cell in Sarcoma
Sun Yat-sen University
Phase 1 Unknown
NCT04172805 2023-04-12
Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04318964 2023-04-12
TAEST16001 in the Treatment of Soft Tissue Sarcoma
Sun Yat-sen University
Phase 1 Unknown
NCT05106777 2023-04-12
Surufatinib in Patients With Osteosarcoma and Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT03985722 2023-03-27
OLATRASTS
Grupo Espanol de Investigacion en Sarcomas
Phase 1 Unknown
NCT04138381 2023-03-27
SeliGIST
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2 Unknown
NCT05131386 2023-03-27
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
Phase 2 Unknown
NCT03475953 2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2 Unknown
NCT02359474 2023-02-28
HyperTET
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT05739084 2023-02-22
RADIOSARC
Centre Leon Berard
Unknown
NCT05656144 2022-12-19
Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT05602415 2022-11-02
Anlotinib and Radiotherapy in Resectable Soft Tissue Sarcoma
Ruijin Hospital
Phase 2 Unknown
NCT05596565 2022-10-27
The Effects of Observer Presence and Type on Patients' Perception of Exercise in Patients With Soft Tissue Sarcoma
Istanbul Medeniyet University
Phase NA Unknown
NCT04012827 2022-09-07
Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT05518526 2022-08-26
ANNA-SARC
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 1/2 Unknown
NCT04960332 2022-07-06
Effect of Negative Pressure Wound Therapy After Surgical Removal of Deep-Seated High-Malignant Soft Tissue Sarcomas of the Extremities and Trunk Wall.
Rigshospitalet, Denmark
Phase NA Unknown
NCT01831609 2022-06-15
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
Samsung Medical Center
Unknown
NCT03802071 2022-06-01
A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue Sarcoma
Yonsei University
Phase 1/2 Unknown
NCT05272358 2022-03-09
OPTISARC
Centre Leon Berard
Unknown
NCT05142631 2022-03-02
Fruquintinib in the Treatment of Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown
NCT02630368 2022-02-02
METROmaJX
Institut Bergonié
Phase 1/2 Unknown
NCT05179850 2022-01-20
Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children
West China Hospital
Unknown
NCT04071704 2022-01-06
Assessing Health-related Quality of Life in Sarcoma Patients
The Netherlands Cancer Institute
Unknown
NCT05171413 2021-12-28
Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma
West China Hospital
Unknown
NCT02106312 2021-08-04
DOREMY
The Netherlands Cancer Institute
Phase 2 Unknown
NCT04619030 2021-06-10
Augmented Reality (AR): The Future of "Patient Information Leaflets
NHS Greater Glasgow and Clyde
Phase NA Unknown
NCT04910126 2021-06-02
Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT04628806 2021-05-14
HSP70CTC
Charite University, Berlin, Germany
Unknown
NCT04765228 2021-02-21
Pegylated Liposomal Doxorubicin Combined With Anlotinib for Neoadjuvant Treatment of Soft Tissue Sarcoma
Fudan University
Phase 2 Unknown
NCT03989596 2021-02-01
SINDIR
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Unknown
NCT03651375 2021-01-22
UN-RESARC
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 2 Unknown
NCT04659733 2020-12-09
Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children
Sun Yat-sen University
Phase 1 Unknown
NCT04606108 2020-10-28
Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of High-risk Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2 Unknown
NCT04518488 2020-09-21
Prehabilitation Soft-Tissue Sarcoma of Lower Limb
McGill University
Phase NA Unknown